0001385508-21-000013.txt : 20210127
0001385508-21-000013.hdr.sgml : 20210127
20210127161308
ACCESSION NUMBER: 0001385508-21-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210126
FILED AS OF DATE: 20210127
DATE AS OF CHANGE: 20210127
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Skolnick Phil
CENTRAL INDEX KEY: 0001358116
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38193
FILM NUMBER: 21559868
MAIL ADDRESS:
STREET 1: C/O DOV PHARMACEUTICAL, INC.
STREET 2: 433 HACKENSACK AVENUE
CITY: HACKENSACK
STATE: NJ
ZIP: 07601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OPIANT PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001385508
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 SANTA MONICA BOULEVARD
STREET 2: SUITE 500
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
BUSINESS PHONE: (310) 598-5410
MAIL ADDRESS:
STREET 1: 201 SANTA MONICA BOULEVARD
STREET 2: SUITE 500
CITY: SANTA MONICA
STATE: CA
ZIP: 90401
FORMER COMPANY:
FORMER CONFORMED NAME: Lightlake Therapeutics Inc.
DATE OF NAME CHANGE: 20091009
FORMER COMPANY:
FORMER CONFORMED NAME: Madrona Ventures, Inc.
DATE OF NAME CHANGE: 20070108
4
1
wf-form4_161178197585449.xml
FORM 4
X0306
4
2021-01-26
0
0001385508
OPIANT PHARMACEUTICALS, INC.
OPNT
0001358116
Skolnick Phil
C/O OPIANT PHARMACEUTICALS, INC.
233 WILSHIRE BLVD., SUITE 280
SANTA MONICA
CA
90401
0
1
0
0
Chief Scientific Officer
Common Stock
2021-01-26
4
A
0
2798
0
A
6948
D
Common Stock
2021-01-26
4
A
0
5400
0
A
12348
D
Stock Option (right to buy)
12.15
2021-01-26
4
A
0
10750
0
A
2031-01-26
Common Stock
10750.0
10750
D
2,798 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. 100% of the RSUs vest on the anniversary date of January 26, 2022, subject to the Reporting Person continuing as a service provider through each such date.
5,400 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule. One-fourth of the RSUs vest on the anniversary dates of January 26, 2022, January 26, 2023, January 6, 2024 and January 26, 2025, subject to the Reporting Person continuing as a service provider through each such date.
On January 26, 2021, the reporting person was granted an option to purchase 10,750 shares of common stock. The option vests as follows: 1/48 of the options become exercisable on the first monthly anniversary of January 26, 2021, the vesting commencement date, and 1/48 of the options become exercisable on such date every month thereafter through the fourth year anniversary of the vesting commencement date.
/s/ Phil Skolnick
2021-01-27